StonvexLoading…
StonvexStonvexStonvexCore line items from NVTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $8.60M | $45.92M | $38.62M | $28.51M |
Operating Income | $-27.77M | $-107.76M | $-66.37M | $-46.96M |
Net Income | $-33.78M | $-116.95M | $-85.14M | $-49.08M |
EPS (Diluted) | $-0.15 | $-0.57 | $-0.43 | $-0.34 |
Total Assets | $481.37M | $500.47M | $430.21M | $449.44M |
Total Liabilities | $61.32M | $56.81M | $59.22M | $60.56M |
Cash & Equivalents | $221.01M | $236.86M | $150.55M | $161.19M |
Free Cash Flow OCF − CapEx | $-16.75M | $-44.37M | $-36.21M | $-25.48M |
Shares Outstanding | 229.99M | 205.57M | 199.93M | 193.46M |